118 related articles for article (PubMed ID: 28295198)
1. Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria.
Stull D; McBride D; Tian H; Gimenez Arnau A; Maurer M; Marsland A; Balp MM; Khalil S; Grattan C
Br J Dermatol; 2017 Oct; 177(4):1093-1101. PubMed ID: 28295198
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Urticaria Activity Score Over 7 Days (UAS7) Values Obtained from Once-Daily and Twice-Daily Versions: Results from the ASSURE-CSU Study.
Hollis K; Proctor C; McBride D; Balp MM; McLeod L; Hunter S; Tian H; Khalil S; Maurer M
Am J Clin Dermatol; 2018 Apr; 19(2):267-274. PubMed ID: 29368043
[TBL] [Abstract][Full Text] [Related]
3. Disease Control and Treatment Satisfaction in Patients with Chronic Spontaneous Urticaria in Japan.
Fukunaga A; Kishi Y; Arima K; Fujita H
J Clin Med; 2024 May; 13(10):. PubMed ID: 38792508
[No Abstract] [Full Text] [Related]
4. Chronic Spontaneous Urticaria: The Devil's Itch.
Saini SS; Kaplan AP
J Allergy Clin Immunol Pract; 2018; 6(4):1097-1106. PubMed ID: 30033911
[TBL] [Abstract][Full Text] [Related]
5. Chronic Spontaneous Urticaria: Quality of Life and Economic Impacts.
Keller L; Stitt J
Immunol Allergy Clin North Am; 2024 Aug; 44(3):453-467. PubMed ID: 38937009
[TBL] [Abstract][Full Text] [Related]
6. Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy.
Deza G; Bertolín-Colilla M; Pujol RM; Curto-Barredo L; Soto D; García M; Hernández P; Gimeno R; Giménez-Arnau AM
Acta Derm Venereol; 2017 Jun; 97(6):698-704. PubMed ID: 28303277
[TBL] [Abstract][Full Text] [Related]
7. Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria.
Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A; González-Aveledo L; Maurer M
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):964-971. PubMed ID: 28299827
[TBL] [Abstract][Full Text] [Related]
8. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
[TBL] [Abstract][Full Text] [Related]
9. Comparison and interpretability of the available urticaria activity scores.
Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
Allergy; 2018 Jan; 73(1):251-255. PubMed ID: 28815631
[TBL] [Abstract][Full Text] [Related]
10. The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.
Maurer M; Abuzakouk M; Bérard F; Canonica W; Oude Elberink H; Giménez-Arnau A; Grattan C; Hollis K; Knulst A; Lacour JP; Lynde C; Marsland A; McBride D; Nakonechna A; Ortiz de Frutos J; Proctor C; Sussman G; Sweeney C; Tian H; Weller K; Wolin D; Balp MM
Allergy; 2017 Dec; 72(12):2005-2016. PubMed ID: 28543019
[TBL] [Abstract][Full Text] [Related]
11. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
Zuberbier T; Aberer W; Asero R; Abdul Latiff AH; Baker D; Ballmer-Weber B; Bernstein JA; Bindslev-Jensen C; Brzoza Z; Buense Bedrikow R; Canonica GW; Church MK; Craig T; Danilycheva IV; Dressler C; Ensina LF; Giménez-Arnau A; Godse K; Gonçalo M; Grattan C; Hebert J; Hide M; Kaplan A; Kapp A; Katelaris CH; Kocatürk E; Kulthanan K; Larenas-Linnemann D; Leslie TA; Magerl M; Mathelier-Fusade P; Meshkova RY; Metz M; Nast A; Nettis E; Oude-Elberink H; Rosumeck S; Saini SS; Sánchez-Borges M; Schmid-Grendelmeier P; Staubach P; Sussman G; Toubi E; Vena GA; Vestergaard C; Wedi B; Werner RN; Zhao Z; Maurer M;
Allergy; 2018 Jul; 73(7):1393-1414. PubMed ID: 29336054
[TBL] [Abstract][Full Text] [Related]
12. Can the response to Omalizumab be influenced by treatment duration? A real-life study.
Sposato B; Scalese M; Latorre M; Novelli F; Scichilone N; Milanese M; Olivieri C; Perrella A; Paggiaro P;
Pulm Pharmacol Ther; 2017 Jun; 44():38-45. PubMed ID: 28302544
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.
Metz M; Staubach P; Bauer A; Brehler R; Gericke J; Kangas M; Ashton-Chess J; Jarvis P; Georgiou P; Canvin J; Hillenbrand R; Erpenbeck VJ; Maurer M
Theranostics; 2017; 7(5):1266-1276. PubMed ID: 28435464
[No Abstract] [Full Text] [Related]
14. Clinical features of adolescents with chronic idiopathic or spontaneous urticaria: Review of omalizumab clinical trials.
Goldstein S; Gabriel S; Kianifard F; Ortiz B; Skoner DP
Ann Allergy Asthma Immunol; 2017 Apr; 118(4):500-504. PubMed ID: 28390587
[TBL] [Abstract][Full Text] [Related]
15. Chronic Idiopathic Urticaria: Systemic Complaints and Their Relationship with Disease and Immune Measures.
Doong JC; Chichester K; Oliver ET; Schwartz LB; Saini SS
J Allergy Clin Immunol Pract; 2017; 5(5):1314-1318. PubMed ID: 28302451
[TBL] [Abstract][Full Text] [Related]
16. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria.
Schmetzer O; Lakin E; Topal FA; Preusse P; Freier D; Church MK; Maurer M
J Allergy Clin Immunol; 2018 Sep; 142(3):876-882. PubMed ID: 29208545
[TBL] [Abstract][Full Text] [Related]
17. Improvement in the quality of life of patients with chronic spontaneous urticaria treated with omalizumab in real life.
Larrea-Baca I; Gurpegui-Resano M
Enferm Clin; 2017; 27(6):361-368. PubMed ID: 28457893
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria.
Hide M; Park HS; Igarashi A; Ye YM; Kim TB; Yagami A; Roh J; Lee JH; Chinuki Y; Youn SW; Lee SK; Inomata N; Choi JH; Fukunaga A; Wang J; Matsushima S; Greenberg S; Khalil S
J Dermatol Sci; 2017 Jul; 87(1):70-78. PubMed ID: 28366435
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
20. The Urticaria Activity Score-Validity, Reliability, and Responsiveness.
Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K
J Allergy Clin Immunol Pract; 2018; 6(4):1185-1190.e1. PubMed ID: 29128337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
